Jun 03, 2022
Shareholder Newsletter June 2022

The Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) Shareholder Newsletter June 2022 is now available to view online.
In this issue:
>> New data for SPL7013 in VIRALEZE™ against influenza and Omicron
>> VIRALEZE™ to relaunch in the UK
>> AstraZeneca expands the clinical program for their DEP® agent, AZD0466
>> Business development and conferences
>> Internal DEP® clinical programs and clinical case studies
>> DEP® gemcitabine clinical study to commence shortly
>> Partnered DEP® programs
>> International rollout of VIRALEZE™
>> New peer-reviewed publication of VivaGel® BV in Archives of Gynecology & Obstetrics
>> Okamoto launches new VivaGel® condom brand in Japan
>> Quarterly Cashflow, Our People, Key Value Drivers & Outlook
Download: Shareholder Newsletter June 2022 (pdf file, 671kb)
This contains certain forward-looking statements.